Rhythm Pharmaceuticals (RYTM) EBIT Margin (QoQ) (2021 - 2026)

Rhythm Pharmaceuticals (RYTM) EBIT Margin (QoQ) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Rhythm Pharmaceuticals 7.95 Bn 7.62 Bn 62.32 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1,897.00
Mar 31, 2026 -490.00
Dec 31, 2025 2,044.00
Sep 30, 2025 -925.00
Jun 30, 2025 5,034.00
Mar 31, 2025 -4,510.00
Dec 31, 2024 3,336.00
Sep 30, 2024 722.00
Jun 30, 2024 39,951.00
Mar 31, 2024 -36,843.00
Dec 31, 2023 2,503.00
Sep 30, 2023 4,715.00
Jun 30, 2023 21,556.00
Mar 31, 2023 -98,117.00
Dec 31, 2022 143,975.00
Sep 30, 2022 -41,918.00
Jun 30, 2022 302,000.00
Mar 31, 2022 -71,120.00
Dec 31, 2021 149,728.00
Sep 30, 2021 1.05 Mn